Clinical value of screening prenatal ultrasound combined with chromosomal microarrays in prenatal diagnosis of chromosomal abnormalities

References

• Tuzimski T, Szubartowski S, Stupak A, et al. The association between the bisphenols residues in amniotic fluid and fetal abnormalities in Polish pregnant women—its potential clinical application. Int J Mol Sci. 2023;24(1):1. doi: 10.3390/ijms24010730.
   Web of Science ®Google Scholar
• Fan L, Wu J, Wu Y, et al. Analysis of chromosomal copy number in first-trimester pregnancy loss using next-generation sequencing. Front Genet. 2020;11:545856. doi: 10.3389/fgene.2020.545856.
   PubMed Web of Science ®Google Scholar
• Harasim T, Neuhann T, Behnecke A, et al. Initial clinical experience with NIPT for rare autosomal aneuploidies and large copy number variations. J Clin Med. 2022;11(2):372. doi: 10.3390/jcm11020372.
   PubMed Web of Science ®Google Scholar
• Chen G, Xiong S, Zou G, et al. A 6.3 Mb maternally derived microduplication of 20p13p12.2 in a fetus with brachydactyly type D and related literature review. Mol Cytogenet. 2022;15(1):6. doi: 10.1186/s13039-022-00584-3.
   PubMed Web of Science ®Google Scholar
• Petersen O, Smith E, Van Opstal D, et al. Nuchal translucency of 3.0–3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review. Acta Obstet Gynecol Scand. 2020;99(6):765–10. doi: 10.1111/aogs.13877.
   PubMed Web of Science ®Google Scholar
• Seeds J. Diagnostic midtrimester amniocentesis: how safe? Am J Obstet Gynecol. 2004;191(2):607–615. doi: 10.1016/j.ajog.2004.05.078.
   PubMed Web of Science ®Google Scholar
• Kong CW, Leung TN, Leung TY, et al. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis. Prenat Diagn. 2006;26:925–930.
   PubMed Web of Science ®Google Scholar
• Enzensberger C, Pulvermacher C, Degenhardt J, et al. Fetal loss rate and associated risk factors after amniocentesis, chorionic villus sampling and fetal blood sampling. Ultraschall Med. 2012;33:75–79.
   PubMedGoogle Scholar
• Piyamongkol W, Wanapirak C, Sirichotiyakul S, et al. A comparison of cordocentesis outcomes between early and conventional procedures. Matern Fetal Neonatal Med. 2012;25(11):2298–2301. doi: 10.3109/14767058.2012.691577.
   PubMed Web of Science ®Google Scholar
• Johnstone-Ayliffe C, Prior T, Ong C, et al. Early procedure-related complications of fetal blood sampling and intrauterine transfusion for fetal anemia. Acta Obstet Gynecol Scand. 2012;91(4):458–462. doi: 10.1111/j.1600-0412.2011.01353.x.
   PubMed Web of Science ®Google Scholar
• Boupaijit K, Wanapirak C, Piyamongkol W, et al. Effect of placenta penetration during cordocentesis at mid-pregnancy on fetal outcomes. Prenat Diagn. 2012;32(1):83–87. doi: 10.1002/pd.2916.
   PubMed Web of Science ®Google Scholar
• Sagi-Dain L, Cohen VL, Kahana S, et al. Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies. Genet Med. 2019;21(11):2462–2467. doi: 10.1038/s41436-019-0550-x.
   PubMed Web of Science ®Google Scholar
• Chen L, He F, Zeng K, et al. Differentiation of cystic biliary atresia and choledochal cysts using prenatal ultrasonography. Ultrasonography. 2022;41(1):140–149. doi: 10.14366/usg.21028.
   PubMed Web of Science ®Google Scholar
• Gu F, Yu J, Mi J. Radial arteriovenous fistula complicated with ischemic steal syndrome after transradial cardiac catheterization: a case report and literature review. BMC Surg. 2022;22(1):106. doi: 10.1186/s12893-022-01562-7.
   PubMed Web of Science ®Google Scholar
• Abishake J, Ninave S, Keerti A. A compendium on perinatal autopsy in neonats. Cureus. 2023;15(1):e33878. doi: 10.7759/cureus.33878.
   PubMed Web of Science ®Google Scholar
• Pan L, Wu J, Liang D, et al. Association analysis between chromosomal abnormalities and fetal ultrasonographic soft markers based on 15,263 fetuses. Am J Obstet Gynecol MFM. 2023;5(10):101072. doi: 10.1016/j.ajogmf.2023.101072.
   PubMed Web of Science ®Google Scholar
• Cai M, Lin N, Chen X, et al. Evaluation of chromosomal abnormalities and copy number variations in fetuses with ultrasonic soft markers. BMC Med Genomics. 2021;14(1):19.
   PubMed Web of Science ®Google Scholar
• Yan L, Caihong L, Yan J. Concordance of chromosomal microarray analysis in prenatal diagnosis of fetuses with abnormal ultrasonographic soft markers. J Coll Physicians Surg Pak. 2023;33(3):270–274.
   PubMed Web of Science ®Google Scholar
• Shaffer LG, McGowan-Jordan J, Schmid M. ISCN 2013: an international system for human cytogenetic nomenclature (2013). Basel: S. Karger AG; 2013.
   Google Scholar
• Liu W, Lu J, Zhang J, et al. A consensus recommendation for the interpretation and reporting of copy number variation and regions of homozygosity in prenatal genetic diagnosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020;37(7):701–708. doi: 10.3760/cma.j.issn.1003-9406.2020.07.001.
   PubMedGoogle Scholar
• Hu X, Hu Y, Wang H, et al. Comparison of chromosomal microarray analysis and noninvasive prenatal testing in pregnant women with fetal ultrasonic soft markers. Risk Manag Healthc Policy. 2024;17:29–40. doi: 10.2147/RMHP.S437441.
   PubMed Web of Science ®Google Scholar
• Getz L, Kirkengen AL. Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas. Soc Sci Med. 2003;56(10):2045–2057. doi: 10.1016/s0277-9536(02)00200-9.
   PubMed Web of Science ®Google Scholar
• Choy KW, Wang H, Shi M, et al. Prenatal diagnosis of fetuses with increased nuchal translucency by genome sequencing analysis. Front Genet. 2019;10:761. doi: 10.3389/fgene.2019.00761.
   PubMed Web of Science ®Google Scholar
• Hu T, Tian T, Zhang Z, et al. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am J Obstet Gynecol. 2021;224(5):516.e1–516.e16.
   PubMed Web of Science ®Google Scholar
• Song T, Xu Y, Li Y, et al. Clinical experience of prenatal chromosomal microarray analysis in 6159 ultrasonically abnormal fetuses. Reprod Sci. 2023. doi: 10.1007/s43032-023-01399-2.
   Google Scholar
• Yuan X, Yong W, Dai L, et al. The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton: a retrospective study. Ann Transl Med. 2023;11(2):111–111. doi: 10.21037/atm-22-6343.
   PubMedGoogle Scholar
• Maya I, Yacobson S, Kahana S, et al. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis. Ultrasound Obstet Gynecol. 2017;50(3):332–335. doi: 10.1002/uog.17421.
   PubMed Web of Science ®Google Scholar
• Carta S, Kaelin Agten A, Belcaro C, et al. Outcome of fetuses with prenatal diagnosis of isolated severe bilateral ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;52(2):165–173. doi: 10.1002/uog.19038.
   PubMed Web of Science ®Google Scholar
• Irani S, Ahmadi F, Javam M, et al. Outcome of isolated fetal choroid plexus cyst detected in prenatal sonography among infertile patients referred to Royan Institute: a 3-year study. Iran J Reprod Med. 2015;13(9):571–576.
   PubMedGoogle Scholar
• Luo S, Meng D, Li Q, et al. Genetic testing and pregnancy outcome analysis of 362 fetuses with congenital heart disease identified by prenatal ultrasound. Arq Bras Cardiol. 2018;111(4):571–577.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu J, Li X, et al. Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester. Zhonghua Fu Chan Ke Za Zhi. 2011;46:644–648.
   PubMedGoogle Scholar
• Zhu H, Jin X, Xu Y, et al. Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age. BMC Pregnancy Childbirth. 2021;21(1):86. doi: 10.1186/s12884-021-03570-6.
   PubMed Web of Science ®Google Scholar
• Huang W, Shih S, Lin C, et al. Pregnant women’s attitudes and decision-making regarding prenatal Down syndrome screening and diagnosis: scale development and validation. BMC Pregnancy Childbirth. 2020;20(1):407. doi: 10.1186/s12884-020-03093-6.
   PubMed Web of Science ®Google Scholar
• Scott F, Peters H, Bonifacio M, et al. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population. Aust N Z J Obstet Gynaecol. 2004;44(3):205–209. doi: 10.1111/j.1479-828X.2004.00205.x.
   PubMed Web of Science ®Google Scholar
• Zheng X, Huang G. Legal issues related to termination of pregnancy of non-severe fetal malformation. China Health Law. 2022;30(1):46–50. doi: 10.19752/j.cnki.1004-6607.2022.01.009.
   Google Scholar